3,5-二(三氟甲基)苯-1-碳酰肼 | 26107-82-4

• 物质功能分类: 有机原料 - 肼或胲的有机衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3,5-二(三氟甲基)苯-1-碳酰肼
• 中文别名: 3,5-二(三氟甲基)苯甲酰肼；3,5-双(三氟甲基)苯酰肼；3,5-二(三氟甲基)苯酰肼
• 英文名称: 3,5-bis(trifluoromethyl)benzohydrazide
• 英文别名: 3,5-bis(trifluoromethyl)benzhydrazide；3,5-bis(trifluoromethyl)benzoyl hydrazide；3,5-bis(trifluoromethyl)benzoylhydrazine
• CAS: 26107-82-4
• 化学式: C₉H₆F₆N₂O
• mdl: MFCD00051848
• 分子量: 272.15
• InChiKey: GBBRFBSFWKFTMZ-UHFFFAOYSA-N

物化性质

• 熔点：
  131-135 °C
• 密度：
  1.479±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  如果按照规格使用和储存，则不会分解。请避免接触氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  18
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  8

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险类别码：
  R36/37/38
• 海关编码：
  2928000090
• 安全说明：
  S26,S37/39
• 储存条件：
  保持贮藏器密封，并将其放入一个紧密封装的容器中。建议存放在阴凉、干燥处。

SDS

Name:	3 5-Bis(trifluoromethyl)benzhydrazide Material Safety Data Sheet
Synonym:
CAS:	26107-82-4

Section 1 - Chemical Product MSDS Name:3 5-Bis(trifluoromethyl)benzhydrazide Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
26107-82-4	3,5-Bis(trifluoromethyl)benzhydrazide		247-462-1

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid generating dusty conditions.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 26107-82-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 132 - 134 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H6F6N2O
Molecular Weight: 272.15

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Hydrogen cyanide, carbon monoxide, oxides of nitrogen, carbon dioxide, hydrogen fluoride gas, nitric acid.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 26107-82-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3,5-Bis(trifluoromethyl)benzhydrazide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 26107-82-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 26107-82-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 26107-82-4 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3,5-二(三氟甲基)苯-1-碳酰肼 在 盐酸 、 sodium cyanoborohydride 作用下， 以 叔丁醇 为溶剂， 生成 N'-benzyl-3,5-bis(trifluoromethyl)benzohydrazide
  参考文献：
  名称：

  Improved Cope-type hydroamination reactivity of hydrazine derivatives

  摘要：

  报道了对无金属、Cope型偶氮胺反应性的肼羧酸及其类似物的系统研究。优化肼羧酸结构使分子内反应更加容易，并实现了烯烃的分子间反应，从而提供了一种直接制备多取代肼羧酸的方法。

  DOI：

  10.1039/c0cc02403a
• 作为产物：
  描述：

  3,5-双(三氟甲基)苯甲酸甲酯 在 一水合肼 作用下， 以 甲醇 为溶剂， 反应 16.0h， 以81.6%的产率得到3,5-二(三氟甲基)苯-1-碳酰肼
  参考文献：
  名称：

  双极性电荷传输嵌段共聚物的合成及有机发光二极管的表征

  摘要：

  通过三氧化胺介导的自由基聚合反应制备了一系列由三苯胺部分作为空穴传输单元和恶二唑部分作为电子传输单元的空穴和电子传输无规和嵌段共聚物。具有叔丁基或三氟甲基2和7的恶二唑单体分别用于共聚。聚合物的光致发光测量表明，三苯胺和恶二唑单元之间的激基复合物的形成倾向于以无规共聚物，嵌段共聚物和聚合物共混物的顺序发生，这意味着嵌段或共混体系中的相分离形态。该聚合物被用于OLED器件，我们发现聚合物层的形态严重影响了器件的性能。包含空穴和电子传输单元且组成为14/86的嵌段共聚物显示出超过10％的最高外部量子效率。©2010 Wiley Periodicals，Inc. J Polym Sci A部分：Polym Chem 48：1461-1468，2010年

  DOI：

  10.1002/pola.23853

文献信息

• Triazole derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US06265426B1

  公开（公告）日：2001-07-24

  The present invention relates to triazole and imidazole derivatives of formula I and to their pharmaceutically acceptable acid addition salts. These compounds are NMDA receptor subtype blockers and are useful for the treatment of diseases related to the NMDA receptor.

  本发明涉及式I的三唑和咪唑衍生物及其药用可接受的酸盐。这些化合物是NMDA受体亚型阻滞剂，对治疗与NMDA受体相关的疾病有用。
• AMINO ALCOHOL DERIVATIVE, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
  申请人：Beijing Foreland Pharma Co., Ltd.

  公开号：US20210347745A1

  公开（公告）日：2021-11-11

  The present invention belongs to the field of medicine, and specifically discloses an amino alcohol derivative represented by Formula I, a pharmaceutically acceptable salt, solvate, polymorph or prodrug thereof. In addition, the present invention also discloses a pharmaceutical composition comprising the above substances, and a use of the substance in the preparation of a medicament for the prevention and treatment of an immune inflammatory disease, or a disease or condition associated with immunological competence such as multiple sclerosis, ALS, CIDP, systemic lupus erythematosus, rheumatoid arthritis, ulcerative colitis, psoriasis, polymyositis, etc.

  本发明属于医学领域，具体公开了由式I表示的氨基醇衍生物，其药学上可接受的盐、溶剂合物、多型或前药。此外，本发明还公开了包括上述物质的药物组合物，以及该物质在制备用于预防和治疗免疫性炎症性疾病或与免疫功能相关的疾病或病症，如多发性硬化症、肌萎缩侧索硬化症、慢性炎性脱髓鞘性多发性神经病、系统性红斑狼疮、类风湿关节炎、溃疡性结肠炎、牛皮癣、多发性肌炎等药物的制备中的用途。
• Polycyclic N-Benzamido Imides with Potent Activity against Vaccinia Virus
  作者：Eva Torres、María D. Duque、Pelayo Camps、Lieve Naesens、Teresa Calvet、Mercè Font-Bardia、Santiago Vázquez

  DOI：10.1002/cmdc.201000306

  日期：2010.12.3

  The synthesis and antiviral activity of a series of novel polycyclic analogues of the orthopoxvirus egress inhibitor tecovirimat (ST-246) is presented. Several of these compounds display sub-micromolar activity against vaccinia virus, and were more potent than cidofovir (CDV). The more active compounds were about 10-fold more active than CDV, with minimum cytotoxic concentrations above 100 μM. Chemical

  介绍了正痘病毒出口抑制剂 tecovirimat (ST-246) 的一系列新型多环类似物的合成和抗病毒活性。其中一些化合物对牛痘病毒表现出亚微摩尔活性，并且比西多福韦 (CDV) 更有效。活性更高的化合物的活性比 CDV 高约 10 倍，最小细胞毒性浓度高于 100 μM。对化合物中存在的两个碳-碳双键进行化学操作，以进一步探索这些新型多环酰亚胺的构效关系。两个碳-碳双键的氢化降低了抗病毒活性，而双键的环丙烷化或环氧化完全消除了抗病毒活性。
• Design, Synthesis, and Study of the Insecticidal Activity of Novel Steroidal 1,3,4-Oxadiazoles
  作者：Shichuang Ma、Weiqi Jiang、Qi Li、Tian Li、Wenjun Wu、Hangyu Bai、Baojun Shi

  DOI：10.1021/acs.jafc.1c00088

  日期：2021.10.6

  was designed and synthesized, and the target compounds were evaluated for their insecticidal activity against five aphid species. Most of the tested compounds exhibited potent insecticidal activity against Eriosoma lanigerum (Hausmann), Myzus persicae, and Aphis citricola. Compounds 20g and 24g displayed the highest activity against E. lanigerum, showing LC50 values of 27.6 and 30.4 μg/mL, respectively

  设计并合成了一系列具有取代的1,3,4-恶二唑结构的新型甾体衍生物，并评估了目标化合物对五种蚜虫的杀虫活性。大多数测试的化合物表现出对鼠尾草（Hausmann）、桃蚜和柑橘蚜的有效杀虫活性。化合物20g和24g对E. lanigerum 的活性最高，LC 50值分别为 27.6 和 30.4 μg/mL。E. lanigerum中肠细胞的超微结构变化通过透射电子显微镜检测，表明这些甾体恶唑衍生物可能通过破坏昆虫中肠细胞的线粒体和核膜来发挥其杀虫活性。此外，田间试验表明，化合物20g表现出与阳性对照毒死蜱和噻虫嗪对E. lanigerum的效果相似，在200 μg/mL剂量下21天后达到89.5%的控制率。我们还通过测定三种杀虫剂解毒酶的活性研究了E. lanigerum 中目标化合物的水解和代谢。复合物20g50 μg/mL 对羧酸酯酶的抑制作用类似于已知的抑制剂磷酸三苯酯。上述结果证明了
• Synthesis, fungicidal activity, and 3D-QSAR of tetrazole derivatives containing phenyloxadiazole moieties
  作者：Yi-Tao Li、Wen-Qiang Yao、Si Zhou、Jun-Xing Xu、Hui Lu、Jian Lin、Xiao-Yun Hu、Shao-Kai Zhang

  DOI：10.1016/j.bmcl.2020.127762

  日期：2021.2

  In an effort to discover new agents with good fungicidal activities against CDM (cucumber downy mildew), a series of tetrazole derivatives containing phenyloxadiazole moieties were designed and synthesized. The EC50 values for fungicidal activities against CDM were determined. Bioassay results indicated that most synthesized compounds exhibited potential in vivo fungicidal activity against CDM. A CoMFA

  为了发现对CDM（黄瓜霜霉病）具有良好杀真菌活性的新药剂，设计并合成了一系列含有苯基恶二唑部分的四唑衍生物。确定针对CDM的杀真菌活性的EC 50值。生物测定结果表明，大多数合成的化合物对CDM表现出潜在的体内杀真菌活性。建立了基于生物活性的CoMFA（比较分子场分析）模型，以识别效率的一些主要结构质量。建立模型的q 2和r 2分别为0.791和0.982，验证了其可靠性和预测能力。三种类似物（q3，q4，q5）是基于模型设计和综合的。所有这些化合物对CDM均表现出显着的杀真菌活性，EC 50为1.43、1.52、1.77 mg·L -1。这项工作可以为进一步的结构优化提供有用的指导。

表征谱图